Literature DB >> 2239780

Physical growth and development of children with type 1 glycogen-storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch.

J I Wolfsdorf1, C R Rudlin, J F Crigler.   

Abstract

Thirteen patients with type 1 glycogen-storage disease (GSD-1) were studied to compare the effects on biochemical control and growth of 2 y of therapy with intermittent feedings of uncooked cornstarch (UCS) at the fasting glucose production rate and therapy with continuous overnight glucose (COG) and dextrose feedings during the day. Mean biochemical abnormalities for the groups were minimized but not normalized by either COG or UCS. Growth progressed normally when COG was started by 1.2 y of age and normal growth rate was maintained by UCS. Weight increased from 101 +/- 3% ideal body weight at onset of COG to 127 +/- 5% during COG and the first year of UCS therapy but did not increase further in the second year. When growth failure occurred before onset of COG [-3.7 SD score for chronological age (SDSCA)], only partial correction (-1.9 SDSCA) to genetic potential for height occurred. Intermittent feeding of UCS provides an effective alternative to COG for the treatment of GSD-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2239780     DOI: 10.1093/ajcn/52.6.1051

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  11 in total

1.  Continuous glucose monitoring in children with glycogen storage disease type I.

Authors:  E Hershkovitz; A Rachmel; H Ben-Zaken; M Phillip
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

2.  Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease.

Authors:  J I Wolfsdorf; J F Crigler
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia.

Authors:  Elizabeth Drake Brooks; Dianne Little; Ramamani Arumugam; Baodong Sun; Sarah Curtis; Amanda Demaster; Michael Maranzano; Mark W Jackson; Priya Kishnani; Michael S Freemark; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

4.  Glycogen storage disease type Ia: frequency and clinical course in Turkish children.

Authors:  I N Saltik; H Ozen; G Ciliv; N Koçak; A Yüce; F Gürakan; G Dinler
Journal:  Indian J Pediatr       Date:  2000-07       Impact factor: 1.967

5.  Metabolic control and renal dysfunction in type I glycogen storage disease.

Authors:  J I Wolfsdorf; L M Laffel; J F Crigler
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

6.  Treatment with low-dose diazoxide in two growth-retarded prepubertal girls with glycogen storage disease type Ia resulted in catch-up growth.

Authors:  J M Nuoffer; P E Mullis; U N Wiesmann
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

7.  Bone mineralisation in type 1 glycogen storage disease.

Authors:  P J Lee; J S Patel; M Fewtrell; J V Leonard; N J Bishop
Journal:  Eur J Pediatr       Date:  1995-06       Impact factor: 3.183

Review 8.  Glycogen storage disease type Ia in canines: a model for human metabolic and genetic liver disease.

Authors:  Andrew Specht; Laurie Fiske; Kirsten Erger; Travis Cossette; John Verstegen; Martha Campbell-Thompson; Maggie B Struck; Young Mok Lee; Janice Y Chou; Barry J Byrne; Catherine E Correia; Cathryn S Mah; David A Weinstein; Thomas J Conlon
Journal:  J Biomed Biotechnol       Date:  2011-01-03

9.  Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia.

Authors:  Hye-Ri Kang; Lauren Waskowicz; Andrea M Seifts; Dustin J Landau; Sarah P Young; Dwight D Koeberl
Journal:  Mol Ther Methods Clin Dev       Date:  2019-02-10       Impact factor: 6.698

10.  Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study.

Authors:  J P Rake; G Visser; D Huismans; S Huitema; E van der Veer; D A Piers; G P A Smit
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.